Skip to content
Preprint · OA via OpenAlex

Inflammatory Biomarkers as Predictors of Mortality and Persistent Symptoms at Follow-up in Patients with Severe COVID-19

Dominic L. Sykes, Christina Maria Van Der Feltz-Cornelis, Luke Holdsworth, Simon Hart P, Joseph O’Halloran, Stephen Holding, Michael Crooks G

· 2022

Abstract

Background Serum inflammatory biomarkers such as C-reactive protein (CRP) are an established tool for predicting mortality in COVID-19 patients. Data have also suggested that such biomarkers are persistently elevated in patients with Long-COVID. In this study we aimed to assess the relationship between a panel of serum biomarkers (CRP, IL-6, troponin-T, and ferritin), inpatient mortality, and persistent symptoms post-discharge in COVID-19 survivors. Methods Data were collected retrospectively for all patients with COVID-19 admitted between 1st September 2020 and 10th January 2021. Admission CRP, IL-6, ferritin, and troponin-T were collected alongside routinely collected clinical data. A standardised dataset was collected for survivors when they attended clinical follow-up with the local post-hospitalisation COVID-19 follow-up service. Results A total of 626 patients (mean age 70.1 [SD=15.8], 55% male) had all biomarkers recorded. The overall mortality rate in this cohort was 28.4%. Higher levels of IL-6 (p<0.001) and troponin-T (p<0.001) were associated with a significantly higher risk of inpatient mortality. A total of 144 patients received 3-month follow-up, the commonest reported symptoms were fatigue (54.2%), breathlessness (52.8%), and sleep disturbance (37.5%). Patients who reported myalgia, low mood, and anxiety were found to have lower median levels of IL-6, CRP, and ferritin, respectively. Conclusions Raised levels of IL-6 and TT on admission are associated with a significantly increased risk of inpatient mortality in those hospitalised with COVID-19, however, raised inflammatory markers at the time of hospital admission show no association with residual symptom burden at 3-month follow-up in surviving patients.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.22541/au.167187484.48355876/v1
Canonical
link ↗
Fetched
2026-10-15 MST

Cite this

APA
Sykes, D.L., Feltz-Cornelis, C.M.V.D., Holdsworth, L., P, S.H., O’Halloran, J., Holding, S., &amp; G, M.C. (2022). Inflammatory Biomarkers as Predictors of Mortality and Persistent Symptoms at Follow-up in Patients with Severe COVID-19. https://doi.org/10.22541/au.167187484.48355876/v1
Vancouver
Sykes DL, Feltz-Cornelis CMVD, Holdsworth L, P SH, O’Halloran J, Holding S, et al. Inflammatory Biomarkers as Predictors of Mortality and Persistent Symptoms at Follow-up in Patients with Severe COVID-19. 2022. doi:10.22541/au.167187484.48355876/v1.
BibTeX
@unpublished{dominic2022Inflam, title = {Inflammatory Biomarkers as Predictors of Mortality and Persistent Symptoms at Follow-up in Patients with Severe COVID-19}, author = {Dominic L. Sykes and Christina Maria Van Der Feltz-Cornelis and Luke Holdsworth and Simon Hart P and Joseph O’Halloran and Stephen Holding and Michael Crooks G}, year = {2022}, doi = {10.22541/au.167187484.48355876/v1}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings